Biotechnology The Dream of HIV Vaccines May Finally Be Coming True In a Phase 1 trial, up to 80 percent of people receiving an mRNA vaccine produced antibodies against HIV.

To make matters worse for the Planet Nine theory, this is the fourth sednoid to be discovered. The other three also exhibit stable orbits, similarly suggesting that any Planet Nine would have to be ...

From the possibilitiy of a widespread HIV cure to the first antimatter qubits, check out this week's awesome tech stories from around the web.

Agents, the third phase of generative AI, are a step up from earlier AI tools. Knowing how they work is rapidly becoming essential.

Daswin De Silva is full professor of AI and Analytics, discipline lead and deputy director of the Center for Data Analytics and Cognition (CDAC), and the deputy chair of the Research and Graduate ...

Energy Anthropic Says AI Needs a Whole Lot More Power—Stat The company predicts the AI industry will consume 50 gigawatts by 2028, and the US is not prepared to build out that much new capacity.

From OpenAI's looming GPT-5 release to five things you need to know about AI now, check out this week's awesome tech stories from around the web.

Computing Meta’s Smart Wristband Can Control Devices Like Tom Cruise in ‘Minority Report’ The wearable translates subtle muscle movements into pinches, swipes, and writing.

Biotechnology Forget the Jab: This Pill Is Packed With mRNA Pills could deliver mRNA vaccines and treatments for other diseases too.

Will is a particle physicist, working at the Large Hadron Collider (LHC), seeking to understand the fundamental behavior of the universe. He is a member of the University of Edinburgh Experimental ...

Why didn’t the universe annihilate itself moments after the big bang? A new finding at Cern on the French-Swiss border brings us closer to answering this fundamental question about why matter ...

Artificial Intelligence AI-Designed Drugs Can Now Target Previously ‘Undruggable’ Proteins in Cancer and Alzheimer’s A new AI tool opens the door for designer protein drugs that tackle pain, cancer, ...